These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4290418)

  • 1. [Therapy of nervous system diseases with ACTH and experimental studies on its mechanism of action, with special reference to the nonadrenal effects of ACTH].
    Hiraki K; Kitajima K; Makihata T; Takahara J; Osato N
    Nihon Rinsho; 1966 Jun; 24(6):1206-14. PubMed ID: 4290418
    [No Abstract]   [Full Text] [Related]  

  • 2. [ACTH and corticosteroid treatment for neurological diseases (author's transl)].
    Neundörfer B
    Nervenarzt; 1981 Aug; 52(8):431-40. PubMed ID: 6269011
    [No Abstract]   [Full Text] [Related]  

  • 3. [Corticoid and ACTH therapy of neurologic diseases].
    Hallen O
    Med Welt; 1973 Jun; 24(23):951-4. PubMed ID: 4355430
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of ACTH on seizure susceptibility in the developing brain.
    Holmes GL; Weber DA
    Ann Neurol; 1986 Jul; 20(1):82-8. PubMed ID: 3017186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of disease on the results of diagnostic tests for use in detecting hyperadrenocorticism in dogs.
    Kaplan AJ; Peterson ME; Kemppainen RJ
    J Am Vet Med Assoc; 1995 Aug; 207(4):445-51. PubMed ID: 7591942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [On the determinism of the "stretch syndrome" in animals. Specificity of action of the ACTH molecule].
    Gessa GL; Vargiu L; Ferrari W
    Pathol Biol; 1967 Feb; 15(3):180-2. PubMed ID: 4292968
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of ACTH upon the serum CPK activity in various neuromuscular diseases].
    Araki S; Narazaki T; Kuroiwa Y
    Igaku To Seibutsugaku; 1967 Jan; 74(1):1-5. PubMed ID: 4292148
    [No Abstract]   [Full Text] [Related]  

  • 8. [Principles and limits of ACTH-cortisone therapy in neurology].
    Bammer HG
    Bibl Psychiatr Neurol; 1969; 139():36-59. PubMed ID: 4332888
    [No Abstract]   [Full Text] [Related]  

  • 9. [Treatment of neurologic diseases with synthetic corticotropin (beta-1-24-corticotropin)].
    Steinbrecher W
    Med Welt; 1969 Nov; 48():2636-49. PubMed ID: 4318400
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of ACTH and corticosteroids on the brain.
    op de Coul AA
    Psychiatr Neurol Neurochir; 1966; 69(6):385-98. PubMed ID: 4291298
    [No Abstract]   [Full Text] [Related]  

  • 11. [Synacthen Depot. Results of the clinical treatment in neurology. Preliminary note].
    Teixeira I; Sztajmberg M
    Hospital (Rio J); 1969 Nov; 76(5):1761-5. PubMed ID: 4313357
    [No Abstract]   [Full Text] [Related]  

  • 12. Adrenocorticotropic hormone, but not trilostane, causes severe adrenal hemorrhage, vacuolization, and apoptosis in rats.
    Burkhardt WA; Guscetti F; Boretti FS; Ivos Todesco A; Aldajarov N; Lutz TA; Reusch CE; Sieber-Ruckstuhl NS
    Domest Anim Endocrinol; 2011 Apr; 40(3):155-64. PubMed ID: 21194873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interference of cortisone and ACTH with brain development? A survey of experimental studies in mice and rats.
    Baier WK
    Neuropadiatrie; 1980 May; 11(2):186-8. PubMed ID: 6160427
    [No Abstract]   [Full Text] [Related]  

  • 14. [Studies on an application of synthetic ACTH (giractide acetate) as a therapeutic agents: the first report of a special reference on therapy of hepatic disease (author's transl)].
    Sugi S; Hara H; Takeda H; Oma H
    Igaku Kenkyu; 1978 Aug; 48(6):488-92. PubMed ID: 219656
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenetic therapy of nervous system and muscular diseases using large doses of prednisolone on alternate days].
    Gekht BM; Kuzin MI; Kolomenskaia EA; Gnezditskaia EV; Zefirova GS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(3):286-90. PubMed ID: 220823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of adrenal cortex hormones in neurological diseases].
    Tsukagoshi H
    Naika; 1965 Jul; 16(1):108-11. PubMed ID: 4287135
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of adrenocorticotropic hormone on nucleic acid and protein synthesis and content in the brain of rat embryos in the early stages of neurogenesis].
    Kotin AM; Chebotar' NA; Tishchenko LI
    Ontogenez; 1978; 9(1):70-7. PubMed ID: 203887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Action of ACTH fragment on the rates aggressive behavior and the distribution of transmitter amino acids in the brain structures].
    Vasadze L; Petriashvili E; Museliani T; Nikolaishvili M; Djariashvili T
    Georgian Med News; 2007 Nov; (152):45-7. PubMed ID: 18175834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in muscle action potentials of patients with diseases of motor units following the infusion of a peptide fragment of ACTH.
    Strand FL; Stoboy H; Friedebold G; Krivoy W; Heyck H; van Riezen H
    Arzneimittelforschung; 1977; 27(3):681-3. PubMed ID: 194605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ACTH and cortisone in the treatment of neurological diseases].
    LAFON R; MINVIELLE J
    Montp Med; 1954 Nov; 46(5):276-83. PubMed ID: 14370103
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.